» Articles » PMID: 17179696

A Case of Hypersensitivity Syndrome to Both Vancomycin and Teicoplanin

Overview
Specialty General Medicine
Date 2006 Dec 21
PMID 17179696
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Drug hypersensitivity syndrome to both vancomycin and teicoplanin has not been previously reported. We describe here a 50-yr-old male patient with vertebral osteomyelitis and epidural abscess who developed hypersensitivity syndrome to both vancomycin and teicoplanin. Skin rash, fever, eosinophilia, interstitial pneumonitis, and interstitial nephritis developed following the administration of each drug, and resolved after withdrawing the drugs and treating with high dose corticosteroids. The vertebral osteomyelitis was successfully treated with 6-week course of linezolid without further complications. Skin patch tests for vancomycin and teicoplanin was done 2 months after the recovery; a weak positive result for vancomycin (10% aq.,+at D2 and +at D4 with erythema and vesicles; ICDRG scale), and a doubtful result for teicoplanin (4% aq.-at D2 and+/-at D4 with macular erythema; ICDRG scale). We present this case to alert clinicians to the hypersensitivity syndrome that can result from vancomycin and teicoplanin, with possible cross-reactivity, which could potentially be life-threatening.

Citing Articles

A rare case of infant eosinophilia induced by oral vancomycin: a case report and literature review.

Wu Y, Yin W, Guo S, Wang F J Int Med Res. 2023; 51(2):3000605231156761.

PMID: 36852821 PMC: 9983108. DOI: 10.1177/03000605231156761.


Associations of and with vancomycin-induced drug reaction with eosinophilia and systemic symptoms in the Han-Chinese population.

Wang C, Lin W, Chen W, Chen C, Lu C, Hou H Front Pharmacol. 2022; 13:954596.

PMID: 36506572 PMC: 9732226. DOI: 10.3389/fphar.2022.954596.


Characterization of Teicoplanin-Specific T-Cells from Drug Naïve Donors Expressing HLA-A*32:01.

Gardner J, Ogese M, Betts C, Pirmohamed M, Naisbitt D Chem Res Toxicol. 2022; 35(2):199-202.

PMID: 35107993 PMC: 9007560. DOI: 10.1021/acs.chemrestox.1c00425.


Vancomycin-Induced Organizing Pneumonia: A Case Report and Literature Review.

Lee Y, Lee Y Medicina (Kaunas). 2021; 57(6).

PMID: 34208316 PMC: 8231184. DOI: 10.3390/medicina57060610.


Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.

Sharifzadeh S, Mohammadpour A, Tavanaee A, Elyasi S Eur J Clin Pharmacol. 2020; 77(3):275-289.

PMID: 33025080 PMC: 7537982. DOI: 10.1007/s00228-020-03005-9.


References
1.
Sullivan J, Shear N . The drug hypersensitivity syndrome: what is the pathogenesis?. Arch Dermatol. 2001; 137(3):357-64. View

2.
Bernedo N, Gonzalez I, Gastaminza G, Audicana M, Fernandez E, Munoz D . Positive patch test in vancomycin allergy. Contact Dermatitis. 2001; 45(1):43. DOI: 10.1034/j.1600-0536.2001.045001043.x. View

3.
Hsu S . Biopsy-proved acute tubulointerstitial nephritis and toxic epidermal necrolysis associated with vancomycin. Pharmacotherapy. 2001; 21(10):1233-9. DOI: 10.1592/phco.21.15.1233.33901. View

4.
Bachot N, Roujeau J . Differential diagnosis of severe cutaneous drug eruptions. Am J Clin Dermatol. 2003; 4(8):561-72. DOI: 10.2165/00128071-200304080-00006. View

5.
Rayner C, Baddour L, Birmingham M, Norden C, Meagher A, Schentag J . Linezolid in the treatment of osteomyelitis: results of compassionate use experience. Infection. 2004; 32(1):8-14. DOI: 10.1007/s15010-004-3029-9. View